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Abstract Crystallographic studies on adenylate kinase (AK) 
suggest that binding of ATP causes the LID domain of the 
enzyme to close over the ATP molecule (Schlauderer et al. (1996) 
J. Mol. Biol. 256, 223-227). The method of time-resolved 
fluorescence resonance energy transfer was applied to study the 
proposed structural change in AK from Esclrerichiu coli. Two 
active derivatives of the (C77S, A73C, V142QAK mutant 
containing the excitation energy donor attached to one of the two 
cysteine residues and the acceptor attached to the other cysteine 
were prepared to monitor displacements of the LID domain in 
response to substrate binding. Binding of either ATP or AMP 
was accompanied by a - 9 A decrease in the interprobe distances 
suggesting LID domain closure. Closure of the LID domain in 
response to AMP binding may be a possible reason for the strong 
AMP-substrate inhibition known for E. coli AK. 
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1. Introduction 
Adenylate kinase (AK) from Escherichiu coli belongs to a 
family of small monomeric enzymes catalyzing the phosphoryl 
transfer reaction (MgATP+AMP e MgADP+ADP [ 11). The 
enzyme consists of the CORE domain (residues l-29, 60- 
119, 158-214) and two small domains, the AMP-binding 
(AMPbind) domain (residues 3&59) and the LID domain (res- 
idues 120-159) [2]. Availability of the crystal structures for 
AKs in the presence of different ligands, and high structural 
similarity found within the AK family, has enabled the deduc- 
tion of a relatively detailed model of the structural transitions 
of the enzyme during catalysis [3]. This model suggests that 
formation of the AK*AMP binary complex is followed by 
closure of the AMPbind domain over the AMP molecule, while 
the position of the LID domain remains unchanged and the 
ATP-binding site is not blocked [4,5]. Formation of the 
AK.ATP binary complex is followed by closure of the LID 
domain of the enzyme over the ATP molecule, while the 
AMPbind domain remains unclosed [6]. Thus, crystallographic 
studies on AKs suggest independent closure of the small do- 
mains of the enzyme following the formation of the ternary 
enzyme-substrate complex. 
To analyze domain closure in AK, we produced a number 
of two-cysteine-containing mutants of the E. coli enzyme, hav- 
ing cysteine residues in the expected movable segments of the 
enzyme molecule. These mutants, labeled with the appropriate 
donor and acceptor fluorescent probes are being used to study 
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structural transitions of the enzyme by the method of fluo- 
rescence resonance energy transfer (ET). The data we recently 
obtained strongly support the proposed structural transitions 
in AK and suggest the closure of the AMPbind domain in 
response to AMP binding [7]. Here we report the evidence 
for the closure of the LID domain of the enzyme in response 
to ATP binding. 
2. Materials and methods 
2.1. Preparation of labeled derivatives 
Recombinant plasmids coding for (C77S, A73C)-AK (&-AK), 
(C77S, V142C)-AK (CId2-AK) and (C77S, A73C, V142C)-AK 
(C&I~~-AK) mutants were prepared by the site-directed mutagenesis 
method described by Kunkel et al. [8]. Mutants were purified as pre- 
viously described [7] and checked for the presence of cysteine residues 
by the Ellman reaction [9]. Labeling of single-cysteine C7s- and (&- 
AK mutants with 5-iodoacetamidosalicylic acid (the donor, D) or 5- 
iodoacetamidofluorescein (the acceptor, A) was performed in 0.1 M 
Tris-HCl (pH 8.0) at a high dye-to-protein molar ratio (10:20). The 
labeled AK derivatives (D,s-AK, Dldz-AK, A7s-AK or A142-AK) were 
separated from the unlabeled mutants by anion exchange chromatog- 
raphy (see Fig. lA-D). The double-labeled AK derivative, A,3D142- 
AK, containing the donor probe attached to Cys-142 and the acceptor 
probe attached to Cys-73, was prepared by a two-step labeling pro- 
cedure. C7sC14~-AK was first reacted with an equimolar amount of 5- 
iodoacetamidosalicvlic acid. After the reaction a mixture of AK de- 
rivatives containing C&142-AK, C~~DI~~-AK, D7sC142-AK and 
D7sD142-AK was separated by anion exchange chromatography (see 
Fig. 1E). The C7sD142-AK derivative was further reacted with 5-io- 
doacetamidofluorescein, and the double-labeled A7&4*-AK deriva- 
tive was purified from the acceptor-unlabeled derivative (Fig. 1F). The 
D7sA142-AK derivative was prepared using a similar procedure. 
The kinetic constants (I&, and V,,) for AK derivatives were meas- 
ured in the direction of ADP formation as described previously [7]. 
The concentration of protein solutions for the labeled AK derivatives 
was determined by the method of Lowry et al. [lo] using wild-type 
AK as a calibration standard. The protein concentration for wild-type 
AK was determined by using the absorption coefficient A~77~ = 0.5 
(mg/ml)-’ cm-l [ 111. 
2.2. Time-resolved energy transfer measurements 
Decay of the donor emission was measured at 20°C using the time- 
correlated single-photon counting system described previously [12]. 
Donor emission was excited at 310 nm and monitored at 435 nm 
(bandwidth, 12 nm). Each set of ET experiments included measure- 
ments of two protein samples (e.g., D7s-AK and D7sA142-AK) pre- 
pared in 0.1 M Tris-HCI (pH 7.5) containing the same protein con- 
centration (0.1 mg/ml) and the same ligand concentration. Efficiency 
of ET (E, was calculated from the average lifetimes of the donor, (z,J 
and (z,&. in the absence and in the presence of the acceptor: 
E= 1-(T,&/(z~). The average lifetime of the donor was determined 
from multiexponential analysis of the donor emission decay: 
(2) = ZiaiTi, where CY., and Zi are the relative amplitude (Ziai = 1) and 
the lifetime of the ith decay component, respectively. Average inter- 
probe distances (R) in the D7sA142-AK and the A7sD142-AK deriva- 
tives were calculated from the respective E values [13,14]: 
R = R0(l/E-1)“6; Ro = (8.79~ 10-5KZn-4QJ~n)1’6 
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where Ro is the Fbrster distance (in A); i? is the orientation factor 
(taken as 2/3); n is the refractive index of the medium between the 
donor and acceptor (taken as 1.34); Qd is the quantum yield of the 
donor in the absence of the acceptor; and Jda is the normalized spec- 
tral overlap integral (in Mm’ cm-’ nm4). The overlap integral, Jda = 
lfd(h)~~(h)h~d~/lfd(h)dh, was calculated using the fluorescence emis- 
sion spectrum of the donor in D73-AK (or D142-AK), fd(h), and the 
absorbtion sectrum of the acceptor in Aldz-AK (or A73-AK), E,(L), 
measured under the respective ligand conditions. Quantum yield of 
the donor was measured relative to that of quinine sulfate (taken to be 
0.55 [15]). The values of Qd in the Dldz-AK and in the D,z-AK 
derivatives in the absence of ligands were 0.28 and 0.33, respectively. 
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3. Results and discussion 
To monitor displacements of the LID domain in AK, dou- 
ble-labeled derivatives of the (C77S, A73C, V142C)-AK mu- 
tant of the E. coli enzyme containing one of the fluorescent 
probes attached to Cys-142 in the LID domain and the other 
attached to Cys-73 in the CORE domain were prepared. Both 
A7sD142-AK and D~~A~~z-AK derivatives were highly active 
(Table 1) and revealed the strong AMP-substrate inhibition 
which is a characteristic feature of wild-type AK (Fig. 2). The 
Fijrster distances (Ros) calculated for thest two derivatives in 
the absence of ligands were 38.3 and 39.4 A, respectively. The 
absorption spectra of both the donor and the acceptor probes 
were independent of the labeling site (examples are presented 
in Fig. 3). The ligands studied (AMP, ATP and bi-substrate 
analogue inhibitor P1,P5-di(adenosine-5’)pentaphosphate 
[AP5A]) affect neither the position of the fluorescence spec- 
trum of the donor (in D,s-AK and Dlhz-AK) nor the absorp- 
tion spectrum of the acceptor (in A7s-AK and A142-AK). Ro 
values corresponding to the different ligand conditions were 
practically the same as those in the absence of ligands. 
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Both the steady-state and the time-resolved ET experiments 
were performed for each of the double-labeled derivatives. 
The steady-state ET experiments included measurements of 
the fluorescence emission spectra of D142-, A~~DIQ- and A7s- 
AK (and of DT3-, D,3Ald2- and A142-AK) and the spectra of 
the same derivatives in the presence of AMP (10 mM), ATP 
(20 mM), MgATP (20 mM) and APsA (1 mM) (as an exam- 
ple, see Fig. 4). (It should be noted that these ligand concen- 
trations were high enough to produce a fully saturated en- 
zyme [7].) These measurements served both as an indication 
of the appropriate conditions for further time-resolved ET 
experiments, and as an independent control for the ET. 
From Fig. 4 it is clear that the yield of the donor emission 
was reduced in the presence of the acceptor in A7sD142-AK 
while the yield of the acceptor emission was increased. This is 
a clear demonstration of ET between the donor and the ac- 
ceptor probes in the DA-AK derivatives. Multiexponential 
analysis of the donor emission decay in the Dld2-AK and 
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Fig. 1. Separation of AK derivatives by anion exchange chromatog- 
raphy on Mono Q column (FPLC). Elution profiles of Dldz-AK 
(A), D7s-AK (B), Ai42-AK (C), A7s-AK (D), two-cysteine-containing 
C7sCi42-AK mutant after the reaction with an equimolar amount of 
5-iodoacetamidosalicylic acid (E), and C7sD142-AK after the reaction 
with 5Godoacetamidofluorescein (F) are shown. 150 pl of each pro- 
tein solution (l-l.5 mg/ml) in 20 mM Tris-HCl (pH 8.0) were ap- 
plied to a Mono Q column (0.5 X 5 cm) equilibrated with the same 
buffer. The column was washed by 5 ml of the buffer and the pro- 
teins were eluted with a linear gradient of NaCl (o-0.3 M) in 30 ml 
of the buffer at a flow rate of 0.5 ml/min. The arrow in panels A-D 
marks the elution volume value corresponding to the peak position 
of the unlabeled C7s-, C142-, C7sC142-AK mutants and wild-type 
AK. The four peaks shown in panel E correspond (from left to 
right) to C&142-AK, C7sD142-AK, D73C142-AK and D73D142-AK. 
The minor and major peaks shown in panel F correspond to 
C~~DI~Z-AK and A7sD142-AK, respectively. 
Table 1 
Apparent kinetic constants of wild-type AK, (C77S, A73C, V142VC)-AK mutant and its double-labeled derivatives 
Enzyme ATP (as variable substratea) AMP (as variable substrateb) 
&) l$_Zrng) $4) &Ymg) 
Wild-type AK 144+4 1050 + 40 33+2 1038 f 50 
(C77S, A73C, V142C)-AK 13324 1040+40 3424 982 5 70 
D&uz-AK 111+8 557 f 30 24f2 633 f 30 
A~~DIu-AK 163f6 943 f 50 43f4 1046 f 60 
Kinetic constants were measured at 25°C in 0.1 M Tris-HCl (pH 7.5) containing 0.1 M KCl. 
‘lbConcentrations of fixed substrates: 0.2 mM AMP (“) and 1 mM ATP (b). 
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Fig. 2. AMP substrate inhibition for wild-type AK (o), D~~A~~z-AK 
derivative (D) and A7sD142-AK derivative (A). Initial velocities of 
AK reaction were measured under conditions described in Table 1. 
A73D142-AK derivatives, and ET efficiencies calculated for dif- 
ferent ligand forms of the A~~D~~z-AK derivative are pre- 
sented in Table 2. Binding of ligands to A~~D~Q-AK caused 
an increase in ET efficiency in the following order: no ligand 
< AMP = ATP = MgATP < AP5A. The same dependence 
was obtained with D73A142-AK. No intermolecular ET was 
detected: the decay of the donor emission in the equimolar 
mixture of D- and A-AK was the same as in the absence of 
the A-AK derivative. 
Average interprobe distances (IPD) in different ligand 
forms of the double-labeled AK derivatives are presented in 
Table 3. For each of the ligand forms studied, IPD in 
D73A142-AK was very similar to that in AT~D~.Q-AK. Binding 
of either ATP or AMP caused a -9 A decrease in IPD. 
Further decrease in IPD (N 3 A) was observed upon the for- 
mation of AK*AP5P complex. According to the proposed 
model of domain closure in AK [3,6], binding of ATP to E. 
coli AK causes closure of the LID domain of the enzyme, 
which is followed by a - 10 a decrease in the C,(73)- 
C&142) distance (see the last column of Table 3). Formation 
“260 360 460 
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Fig. 3. Absorption spectra of D142-AK (- ~ --) and Ais-AK (p) 
in 0.1 M Tris-HCl (pH 7.5). The absorption spectra of D;s-AK and 
A~Q-AK (not shown) are almost identical to those of Dlaz-AK and 
A7s-AK, respectively. 
of the AK*AP5P ‘ternary’ complex causes a further closure of 
the LID domain, which is followed by a further 34 A de- 
crease in the &(73)-C&(142) distance. Thus, the data ob- 
tained strongly support the proposed closure of the LID do- 
main of AK in response to ATP (or APsP) binding. 
Furthermore, our data suggest that AMP binding causes clo- 
sure of the LID domain of AK to approximately the same 
extent as does ATP binding. 
The mechanisms underlying the strong AMP-substrate in- 
hibition in E. coli AK is a subject of much discussion [18-211. 
Two opposing models were reported to explain the phenom- 
enon. The first of these is a competitive inhibition model, 
which suggests that AMP possesses a relatively high affinity 
towards the ATP binding site [19]. The second model fails to 
address this possibility, and considers the inhibition to be of a 
pure uncompetitive type [20]. Up to now there is no convinc- 
ing evidence for one or other of these models. However, it is 
known that E. coli AK does not show clear competitive in- 
hibition [18,20]. Direct binding studies revealed only one bind- 
ing site for AMP [ll] in the wild-type enzyme. Furthermore, 
crystallographic studies on E. coli AK complexed with both 
AMP and the ATP analogue molecules showed that AMP 
occupies only its own binding site (no AMP was found bound 
Table 2 
Multiexponential analysis of the time-resolved fluorescence of the donor in D~Q- and AT3 D,,Q-AK derivatives under different ligand conditions 
Ligand zd’ (ns) 7dah (ns) E _ 
z1 72 (Td) x2 71 
(a11 (a21 (al) ;:2, 
(zd) x2 
(o/0)(’ 
None 1.84 1.43 5.98 1.16 1.81 6.53 5.35 I .20 10.5 i: 1.3 
(0.26) (0.74) (0.25) (0.75) 
10mM AMP 1.76 7.17 5.82 1.28 1.89 5.65 4.37 1.57 24.9? 1.1 
(0.25) (0.75) (0.34) (0.66) 
20 mM ATP 1.69 7.03 5.64 1.39 1.87 5.64 4.13 1.38 26.8 * 1 .o 
(0.26) (0.74) (0.40) (0.60) 
20 mM MgATP 1.51 6.93 5.41 1.78 1.88 5.36 3.93 1.64 27.4? 1 .O 
(0.28) (0.72) (0.41) (0.59) 
1 mM APsA 1.62 7.26 5.85 1.33 1.68 5.25 3.93 2.06 32.8 + 1.0 
(0.25) (0.75) (0.37) (0.63) 
Measurements of the time-resolved fluorescence of the donor were performed using 310-nm excitation. Donor emission was recorded at 435 nm. 
a,bDecay parameters of the donor emission in D2-AK (b) and D2AI-AK (‘): ‘ti and ai are the lifetime and the relative amplitude of the ith decay 
component, respectively (errors in zi and CL, are f 10% of the presented values); (rd) and (&) are the average (amplitude-weighted) lifetimes of the 
donor in Dz- and D2A1-AK, respectively (errors in the average lifetimes are + 1% of the presented values). 
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Fig. 4. Fluorescence emission spectra of D~Q-AK (- - -), 
A7sD4a-AK ( p) and A7s-AK (- - -) measured in the absence 
of ligands (A) and in the presence of 1 mM APsA (B). The wave- 
length of excitation was 310 nm. The bandwidths were 16 nm at 
both the excitation and emission monochromators. The concentra- 
tion of each protein solution (prepared in 0.1 M Tris-HCl (pH 7.5)) 
was 0.1 mg/ml. 
Table 3 
Average interprobe distances in different ligand forms of D73A142- 
and A7sDida-AK 
Ligand Interprobe distance (A) R myst a (8) 
D~~&~z-AK hhz-AK 
None 54.5 f 2.0 54.8f2.1 51.7 
AMP 45.1 f 1.4 46.1 f 1.5 51.6 
ATP 46.9 f 1.5 45.3 f 1.4 41.6 
APsA 42.9+ 1.3 43.0 f 1.3 37.3 (39.0) 
&Distances between C, atoms of those amino acid residues structur- 
ally equivalent to residues 73 and 142 of E. coli AK [3], in the crystal 
structures of: apo-AK (for E. coli AK) [2], AK-AMP binary complex 
(for AK from beef mitochondrial matrix) [4], AK.AMPPCFsP binary 
complex (for the mutant enzyme of yeast AK) [6] and AKeAPsA 
pseudoternary complex (E. coli AK) [16]. The value in parentheses 
is the corresponding distance in the crystal structure of AK*APsA 
complex for yeast AK [17]. 
to the ATP site) [22]. These experimental data exclude the 
possibility of strong affinity of AMP towards the ATP binding 
site. 
The data we obtained here suggest that the binding of AMP 
causes closure of the LID domain. The closure of the LID 
domain in response to AMP binding can prevent further bind- 
ing of ATP to the ATP binding site, resulting in uncompeti- 
tive inhibition. One question which remains unclear is whether 
the closure of the LID domain occurs upon the formation of 
the AK*AMP binary complex (when AMP binds to the AMP 
binding site) or upon the further formation of the AMP-AK- 
*AMP ternary complex (when the second AMP molecule 
binds to the ATP binding site). If the first is true, then the 
AMP inhibition is uncompetitive. If the second situation is 
true, the inhibition could be much stronger than in the case 
of pure competitive inhibition. In either case, closure of the 
LID domain in response to AMP binding may explain the 
strong AMP-substrate inhibition known for E. coli AK. 
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